Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer
Source: Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry - Category: Allergy & Immunology Authors: Ghasemi, Arash Danesh, Behzad Yazdani-Charati, Jamshid Hosseinimehr, Seyed J. Tags: Articles Source Type: research
More News: Allergy | Allergy & Immunology | Breast Cancer | Cancer | Cancer & Oncology | Celebrex | Chemistry | Radiation Therapy | Skin | Toxicology